Fast Growth Expected For OTCs In Indonesia

17 February 1997

Between 1996 and 2001, the market for over-the-counter medicines inIndonesia will experience a compound annual growth rate of 19.3% in local currencies, and by 2001 the OTC market will represent 39.9% of Indonesia's total pharmaceutical market compared with a 39.1% share in 1996, according to OTCFar East, a new report published by IMS SelfMedication.

Indonesia is one of the fastest-growing OTC markets in the Far East region, according to the study. Its people are used to the concept of self-medication, through the use of traditional Jamu medication, from childhood. Western medicines are relatively new to many, but they tend to be preferred for problems which require rapid relief, while Jamu is used more to preserve well-being. Indonesians also seldom visit a doctor; the additional time and cost mean that they will only consider this when they are really ill, preferring to self-medicate if possible.

Prescription products are perceived by Indonesians as "stronger" than OTCs, and this often equates to a perception of more side effects. Thus, OTCs are seen to be safer than prescription drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight